Optogenetics: A new tool for cancer investigation and treatment

Siamak Alizadeh ^1,2 , Abolghasem Esmaeili ¹, Jaleh Barar ² , Yadollah Omidi ³ *

Cited by CrossRef: 1

1- Ijaz S, Iqbal J, Abbasi B, Tufail A, Yaseen T, Uddin S, Usman K, Ullah R, Bibi H, Inam P, Sagindykova E, Gürer E, Habtemariam S, Calina D, Sharifi‐Rad J. Current stage of preclinical and clinical development of guggulsterone in cancers: Challenges and promises. Cell Biology International. 2024;48(2):128 [Crossref]

2- Huang Q, Hu B, Zhang P, Yuan Y, Yue S, Chen X, Liang J, Tang Z, Zhang B. Neuroscience of cancer: unraveling the complex interplay between the nervous system, the tumor and the tumor immune microenvironment. Mol Cancer. 2025;24(1) [Crossref]

3- Senevirathne A, Lloren K, Aganja R, Kwon J, Lee J. Transforming bacterial pathogens into wonder tools in cancer immunotherapy. Molecular Therapy. 2025;33(3):866 [Crossref]

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate (2024): 20%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded; Google Scholar; SJR; Essential Science Indicators; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO
Member of COPE
Follower of ICMJE
Permission: Creative Commons